Barcelona 2022

Browse: Pre-Congress Content Sunday, 04.09.2022 Monday, 05.09.2022 Tuesday, 06.09.2022		Monday, 14.11.2022 Tuesday, 15.11.2022 Wednesday, 16.11.2022 Thursday, 17.11.2022 Friday, 18.11.2022

Citations should be made in the following way: Authors. Title. Eur Respir J 2022; 60: Suppl. 66, abstract number.

Thoracic oncology

State of the art session
Chairs: G. Hardavella (Athens, Greece), T. Blum (Berlin, Germany), J. Chorostowska-Wynimko (Warsaw, Poland)
Aims: to highlight the latest developments and controversies in lung cancer management; to cover four key areas in which critical new observations have been made in the past year; to provide consolidated updates in order to improve clinical management of lung cancer patients.

Download all media

Patient's testimony S. Cotter (Clarecastle, Ireland)
Does aggressive surgical management of oligometastatic disease pay off? S. Elia (Roma (RM), Italy)
Recent advances in novel targeted therapies for non-small cell lung cancer and implications for current practice J. van Meerbeeck (Edegem (Antwerp), Belgium)
Incorporating immunotherapy in early-stage lung cancer management J. Chorostowska-Wynimko (Warsaw, Poland)
Dyspnoea management in lung cancer: Pandora's box? I. Higginson (London, United Kingdom)
Discussion and Q&A